About Me
Dr. Hillel Grossman is Co-Director of the Clinical Research Core of the Alzheimer's Disease Research Center and Clinical Director of the Mount Sinai Memory and Aging Center. Dr. Grossman is a psychiatrist by training with a focus in geriatric neuropsychiatry and has been involved in designing and conducting clinical studies in Alzheimer's disease. His studies are both observational, e.g. what happens as Alzheimer's progresses and interventional e.g. clinical trials. At present he is the Principal Investigator or Co-Principal investigator on numerous studies of potential treatments or diagnostic tools for Alzheimer's disease. Dr. Grossman has received funding from the NIH, VA and foundations for his investigations of interaction between Alzheimer's and Type II diabetes mellitus and the potential use of a natural insulin sensitizer, NIC5-15, in Alzheimer's disease. Dr. Grossman has also conducted work in the relationship late life depression and cognitive performance in HIV-1 infection.
Language
Position
ASSOCIATE PROFESSOR | PsychiatryHospital Affiliations
About Me
Dr. Hillel Grossman is Co-Director of the Clinical Research Core of the Alzheimer's Disease Research Center and Clinical Director of the Mount Sinai Memory and Aging Center. Dr. Grossman is a psychiatrist by training with a focus in geriatric neuropsychiatry and has been involved in designing and conducting clinical studies in Alzheimer's disease. His studies are both observational, e.g. what happens as Alzheimer's progresses and interventional e.g. clinical trials. At present he is the Principal Investigator or Co-Principal investigator on numerous studies of potential treatments or diagnostic tools for Alzheimer's disease. Dr. Grossman has received funding from the NIH, VA and foundations for his investigations of interaction between Alzheimer's and Type II diabetes mellitus and the potential use of a natural insulin sensitizer, NIC5-15, in Alzheimer's disease. Dr. Grossman has also conducted work in the relationship late life depression and cognitive performance in HIV-1 infection.
Language
Position
ASSOCIATE PROFESSOR | PsychiatryHospital Affiliations
About Me
Dr. Hillel Grossman is Co-Director of the Clinical Research Core of the Alzheimer's Disease Research Center and Clinical Director of the Mount Sinai Memory and Aging Center. Dr. Grossman is a psychiatrist by training with a focus in geriatric neuropsychiatry and has been involved in designing and conducting clinical studies in Alzheimer's disease. His studies are both observational, e.g. what happens as Alzheimer's progresses and interventional e.g. clinical trials. At present he is the Principal Investigator or Co-Principal investigator on numerous studies of potential treatments or diagnostic tools for Alzheimer's disease. Dr. Grossman has received funding from the NIH, VA and foundations for his investigations of interaction between Alzheimer's and Type II diabetes mellitus and the potential use of a natural insulin sensitizer, NIC5-15, in Alzheimer's disease. Dr. Grossman has also conducted work in the relationship late life depression and cognitive performance in HIV-1 infection.
Language
Position
ASSOCIATE PROFESSOR | PsychiatryHospital Affiliations
Education
MD, University of Tennessee
Residency, Clinical Psychiatry
Johns Hopkins Hospital
Fellowship, Geriatric Neuropsych
Univeristy of Rochester
Certifications
Psychiatry, American Board of Psychiatry and Neurology
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Grossman during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- James J. Peters VA Medical Center (Bronx VA)
Scientific Advisory Board:
- Early Alzheimer Foundation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors
Accepting New Patients
